Mokhtar Milaninia MD is categorized under Physicians Offices in Towson, MD and active since 2010.
Mokhtar Milaninia MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Milaninia Mokhtar at the company’s single location by writing to 8203 Ruxton Crossing Court, Towson, Maryland MD 21204 or by phoning (410) 296-4422. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mokhtar Milaninia MD |
| Contact Person: | Milaninia Mokhtar |
| Address: | 8203 Ruxton Crossing Court, Towson, Maryland 21204 |
| Phone Number: | (410) 296-4422 |
| Website Address: | addictionfriction.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mokhtar Milaninia MD was started in 2010 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Milaninia Mokhtar for inquiries that concern Mokhtar Milaninia MD by calling the company number (410) 296-4422, as your correspondence is most welcome. Additionally, the physical location of the single location of Mokhtar Milaninia MD can be found at the coordinates 39.415196,-76.636756 as well as the street address 8203 Ruxton Crossing Court in Towson, Maryland 21204.
For its online presence, you may visit Mokhtar Milaninia MD’s website at addictionfriction.com and engage with its social media outlets through on Twitter and on Facebook.